Reviews of Hims

Hims is a direct-to-consumer telehealth brand based in the United States, launched in 2017. It operates as part of Hims & Hers Health, Inc., offering online consultations and prescription delivery for a variety of conditions, including sexual health, mental health, dermatology, and hair loss. The company is not a laboratory and does not manufacture its own active pharmaceutical ingredients; instead, it prescribes and sells medications that are already FDA-approved, repackaged under the Hims brand. For hair loss, Hims’ main products are generic versions of finasteride and minoxidil, sold either separately or as combined treatments. They also market supplements, thickening shampoos, and conditioners, but these are considered cosmetic rather than therapeutic. Hims does not develop novel compounds or new active ingredients targeted at androgenic alopecia or DHT. Their focus is on accessibility, providing common treatments through a streamlined subscription service rather than innovating in drug development. Community sentiment around Hims tends to be divided. Many users appreciate the convenience, discreetness, and affordability compared to traditional doctor visits. On the other hand, frequent criticisms are that Hims is primarily a marketing company, packaging generic drugs with heavy branding and limited medical oversight. Some patients have expressed concern that the online consultation model may lead to superficial assessments of complex health issues. Overall, Hims is seen more as a consumer health brand than a scientific innovator. It makes existing treatments more accessible but does not contribute to advancing research into androgenic alopecia or developing new therapeutic agents. For community opinions and progress reports on people using Hims